Digestive Health

Obeticholic acid (Ocaliva) is indicated for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA.

Phazyme is used to treat symptoms of gas, such as belching, bloating, and pressure in the stomach/gut.

A significantly greater proportion or patients treated with either 15 or 30 mg show remission or endoscopic response or remission at week 52 compared with the placebo.

Mesalamine is used to treat and prevent flare-ups of mild to moderately active ulcerative colitis.

Vedolizumab (Entyvio) is indicated for adult patients with moderately to severely active ulcerative colitis and adult patients with moderately to severely active Crohn disease.

Oxy-Powder is designed to clean the digestive tract and oxidize and decrease the amount of impacted fecal matter.

The Voquezna Triple Pak (vonoprazan, amoxicillin, clarithromycin) and Voquezna Dual Pak (vonoprazan, amoxicillin) were previously granted priority review designation by the FDA for H. pylori infection.

Prunelax is a laxative made of natural Senna leaves to relieve occasional constipation.

Pedialyte replaces fluids, electrolytes, and minerals lost from diarrhea and vomiting.

Alka-Seltzer relieves heartburn, upset stomach, and acid indigestion.

Kaopectate treats diarrhea, heartburn, nausea, and upset stomach.

Zantac can treat and prevent heartburn, as well as treating stomach ulcers, gastroesophageal reflux disease, and conditions that cause too much stomach acid.

Bismuth subsalicylate is indicated for heartburn, indigestion, and upset stomach.

Culturelle Probiotics Kids supports immune and digestive health.

Offer suggestions for nonprescription products when appropriate, but urge consultation with health care providers if self-treatment is not advisable.

Inflammatory bowel disease has complex treatment options, but pharmacists can help patients make the right choice.

Rabeprazole (AcipHex) can treat erosive or ulcerative gastroesophageal reflux disease, heartburn, stomach ulcers, and esophageal damage.

Purelax aids in the treatment of occasional constipation and irregularity.

The drug met the co-primary endpoints of clinical remission at both weeks 12 and 52 and all key secondary endpoints in the study.

Acid controllers relieve heartburn associated with indigestion.

Patients treated with upadacitinib achieved clinical remission of ulcerative colitis more frequently through weeks 8 and 52 versus the placebo group.

Zegerid is indicated for the treatment of frequent heartburn.

Nexium 24 HR offers relief of frequent heartburns.

Upadacitinib (Rinvoq) is a Janus kinase (JAK) inhibitor being investigated to treat rheumatoid arthritis, Crohn disease, ulcerative colitis, atopic dermatitis, psoriatic arthritis, axial SpA giant cell arteritis, and Takayasu arteritis

The drug has achieved both primary endpoints of clinical remission and endoscopic response at week 12 compared with the placebo, the company says.

Study shows that high infliximab trough levels linked to a low risk of relapse after switching to subcutaneous infliximab in patients with inflammatory bowel disease.

Imodium provides relief of acute nonspecific diarrhea and chronic diarrhea associated with inflammatory bowel disease.

Beano helps prevent flatulence, abdominal bloating, and stomach pain.

Genexa provides relief for the symptoms of heartburn, acid indigestion, and sour stomach.

FlorastorKids is a daily probiotic supplement for children’s digestive and immune support.